HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Infectious Diseases

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/317642PMID 11076705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children.

  1999cited by this paper
• HLA class II factors associated with Plasmodium falciparum merozoite surface antigen allele families.

  1999cited by this paper
• Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

  1998cited by this paper
• How the MHC selects Th1/Th2 immunity.

  1998cited by this paper
• Association of malaria parasite population structure, HLA, and immunological antagonism.

  1998cited by this paper
• HLA class II-associated polymorphism of interferon-gamma production. Implications for HLA-disease association.

  1997cited by this paper
• HLA class I-associated resistance to severe malaria: a parasitological re-assessment.

  1997cited by this paper
• T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic

  1997cited by this paper
• Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

  1996cited by this paper
• Malaria pigment in leucocytes.

  1995cited by this paper
• Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria.

  1995cited by this paper
• Human leucocyte antigen (HLA) and malaria morbidity in a Gambian community.

  1993cited by this paper
• The role of CD4+ T cells in immunity to malaria sporozoites.

  1993cited by this paper
• Molecular analysis of the association of HLA-B53 and resistance to severe malaria

  1992influential reference
• Common West African HLA antigens are associated with protection from severe malaria

  1991influential reference
• Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes.

  1989cited by this paper
• Expression of class I and class II major histocompatibility complex antigens on human hepatocytes

  1988cited by this paper
• HLA Class I-associated Resistance to Severe Malaria : A Parasitological Re-assessment

  year unknowncited by this paper

• Computational Prioritization of T Cell Epitopes to Overcome HLA Restriction and Antigenic Diversity in Plasmodium falciparum

  2025cites this paper
• Mouse Models for Unravelling Immunology of Blood Stage Malaria

  2022cites this paper
• Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso

  2021cites this paper
• Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda

  2020influential citation
• Comprehensive Review of Human Plasmodium falciparum-Specific CD8+ T Cell Epitopes

  2019cites this paper
• First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children

  2018cites this paper
• Host Genetic Predisposition to Malaria

  2018cites this paper
• Major histocompatibility complex and its importance towards controlling infection

  2017cites this paper
• HLA-A Alleles Differentially Associate with Severity to Plasmodium falciparum Malaria Infection in Ibadan, Nigeria

  2017cites this paper
• Diabetic ( NOD ) Mice Lack a Protective B-Cell Response against the ( Nonlethal ) Plasmodium yoelii 17 XNL Malaria Protozoan

  2016cites this paper
• Nonobese Diabetic (NOD) Mice Lack a Protective B-Cell Response against the “Nonlethal” Plasmodium yoelii 17XNL Malaria Protozoan

  2016cites this paper
• The role of vitamin D in malaria.

  2015cites this paper
• IL10A genotypic association with decreased IL-10 circulating levels in malaria infected individuals from endemic area of the Brazilian Amazon

  2015cites this paper
• Review The role of Vitamin D in malaria

  2015cites this paper
• In silico prediction of b-cell and t-cell epitopes in plasmodium falciparum merozoite invasion proteins (eba175, rh5 and ripr)

  2014cites this paper
• Global distribution of malaria-resistant MHC-HLA alleles: the number and frequencies of alleles and malaria risk

  2014cites this paper
• Progress and Challenges towards the Development of Malaria Vaccines

  2012cites this paper
• Association of HLA alleles with Plasmodium falciparum severity in Malian children

  2011cites this paper
• An engineered Plasmodium falciparum C‐terminal 19‐kilodalton merozoite surface protein 1 vaccine candidate induces high levels of interferon‐gamma production associated with cellular immune responses to specific peptide sequences in Gambian adults naturally exposed to malaria

  2011cites this paper
• Effect of schistosoma infection on malaria immune response: A systematic review

  2011cites this paper
• Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase

  2011cites this paper
• Infectious disease — a genetic view

  2011cites this paper
• Plasma Concentration of Malaria Parasite-Derived Macrophage Migration Inhibitory Factor in Uncomplicated Malaria Patients Correlates with Parasitemia and Disease Severity

  2010cites this paper
• Interferon‐γ—central mediator of protective immune responses against the pre‐erythrocytic and blood stage of malaria

  2010cites this paper
• Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins.

  2009cites this paper
• Influência de variantes de receptores de reconhecimento padrão na suscetibilidade à malária

  2008cites this paper
• Influência de variantes de receptores de reconhecimento padrão na suscetibilidade à malária

  2008cites this paper
• HLA-DRB1*04 allele is associated with severe malaria in northern Ghana.

  2008cites this paper
• Human genetic factors involved in immunity to Plasmodium falciparum infection

  2008cites this paper
• Evolution and selection of human leukocyte antigen alleles by Plasmodium falciparum infection.

  2008cites this paper
• Complement receptor 1 and the molecular pathogenesis of malaria

  2007cites this paper
• Murine Immune Responses to Liver-Stage Antigen 1 Protein FMP011, a Malaria Vaccine Candidate, Delivered with Adjuvant AS01B or AS02A

  2006cites this paper
• Role of the HLA-DQ locus in the development of chronic gastritis and gastric carcinoma in Mexican patients.

  2006cites this paper
• Polymorphisms of transporter associated with antigen processing type 1 (TAP1), proteasome subunit beta type 9 (PSMB9) and their common promoter in African children with different manifestations of malaria

  2005cites this paper
• The dissection of CD8 T cells during liver-stage infection.

  2005cites this paper
• Genetic diversity of Plasmodium falciparum infections : Influence on protective malaria immunity

  2005cites this paper
• Polymorphisms of the HLA-B and HLA-DRB1 genes in Thai malaria patients.

  2005cites this paper
• Identification and analysis of a novel scavenger receptor-like protein conserved in Plasmodium species

  2004cites this paper
• Complement receptor one polymorphisms and susceptibility to severe malaria

  2004cites this paper
• Gamma Interferon Responses to Plasmodium falciparum Liver-Stage Antigen 1 and Thrombospondin-Related Adhesive Protein and Their Relationship to Age, Transmission Intensity, and Protection against Malaria

  2004cites this paper
• Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I

  2003cites this paper
• Immunity to liver stage malaria

  2003cites this paper
• Exoerythrocytic malaria vaccine development: understanding host–parasite immunobiology underscores strategic success

  2002cites this paper
• Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children.

  2002cites this paper
• TNFalpha-308A associated with shorter intervals of Plasmodium falciparum reinfections.

  2002cites this paper
• Age-dependent enhancement of IFN-γ responses to Plasmodium falciparum liver stage antigen-1 T cell epitopes

  2002cites this paper
• Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions.

  2002cites this paper
• Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations.

  2002cites this paper
• Immune responses to liver-stage parasites: implications for vaccine development.

  2002cites this paper
• Candidacy of liver stage antigen-1 for Plasmodium falciparum vaccine development

  2001cites this paper